In conclusion, via a meta-analysis of the data from 58 articles and on 48903 participants, we provide evidence that the APEX1 Asp148Glu polymorphism might be a genetic risk factor for the development of gastric cancer. The gene discussed is APEX1; the disease is gastric cancer.